Brands and generics pharmaceuticals…
The case is Federal Trade Commission v. Watson Pharmaceuticals et al, No. 12-416. Via the New York Times comes this note: Last year, for the third time since 2003, the 11th Circuit upheld the agreements as long as the allegedly anticompetitive behavior that results — in this case, keeping the generic drug off the market […]